Cargando…

TOCILIZUMAB IN COVID-19: EAST-AFRICAN EXPERIENCE

Detalles Bibliográficos
Autores principales:	SHAH, R., SHAH, J., REVATHI, G., GOHIL, J., SALEH, M., SURANI, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:	Critical Care
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212597/ http://dx.doi.org/10.1016/j.chest.2021.12.264

Ejemplares similares

TOCILIZUMAB USE IN SEVERE COVID-19: A SINGLE CENTER EXPERIENCE
por: Poon, Joseph, et al.
Publicado: (2020)

Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya
por: Shah, Reena, et al.
Publicado: (2022)

IMPROVED SURVIVAL OUTCOME IN PATIENTS WITH SARS-COV-2 (COVID-19) ARDS WITH TOCILIZUMAB ADMINISTRATION
por: Wadud, Nafisa, et al.
Publicado: (2020)

REMDESIVIR PLUS DEXAMETHASONE VS TOCILIZUMAB OR BARICITINIB SUPPLEMENTATION INITIATED INSIDE 48 HOURS OF INDEX COVID-19 HOSPITALIZATION IN ICU PATIENTS
por: WILLIAMS, STEPHANIE N, et al.
Publicado: (2022)

CHANGING MORTALITY WITH ECLS IN COVID-19: ONE TERTIARY CENTER'S LONGITUDINAL EXPERIENCE
por: CARLISLE, G., et al.
Publicado: (2022)

VV-ECMO IN PATIENTS WITH COVID-19: SURVIVAL PREDICTION SCORE COMPARISON
por: SHAH, ROSHAN, et al.
Publicado: (2021)

ELEVATED CREATINE PHOSPHOKINASE IN PATIENTS WITH COVID-19
por: BHALLA, SUSHEN, et al.
Publicado: (2022)

SHAKEN, NOT STIRRED: HIGH FREQUENCY PERCUSSIVE VENTILATION AS A SALVAGE THERAPY IN SEVERE ARDS DUE TO COVID-19
por: KHURANA, NEHARIKA, et al.
Publicado: (2021)

PNEUMOTHORAX IN SEVERELY ILL PATIENTS WITH COVID-19: SINGLE-CENTER RETROSPECTIVE CASE SERIES
por: SHAH, ROSHAN, et al.
Publicado: (2021)

REACTIVATION OF EPSTEIN-BARR VIRUS AND CYTOMEGALOVIRUS INFECTION IN PATIENTS WITH COVID-19
por: ALMAGUER, ANGELICA, et al.
Publicado: (2022)

LOW CD4+ COUNT CORRELATION WITH INFLAMMATORY MARKERS IN ACUTE COVID-19
por: RAMIREZ, CLAUDIA, et al.
Publicado: (2022)

LOW CD8+ COUNT CORRELATION WITH INFLAMMATORY MARKERS IN ACUTE COVID-19
por: ZIAD, MOHAMED, et al.
Publicado: (2022)

A COLD CASE OF COVID-19-INDUCED COLD AGGLUTININ DISEASE
por: DOUEN, AARON, et al.
Publicado: (2021)

High-flow nasal cannula therapy in a predominantly African American population with COVID-19 associated acute respiratory failure
por: Nguyen, Paul L, et al.
Publicado: (2021)

HOW COMMUNICATION HAS CHANGED DURING COVID-19 PANDEMIC: OUR EXPERIENCE
por: FALSINI, L., et al.
Publicado: (2022)

PROVIDER EXPERIENCE WITH PRONE POSITIONING FOR ARDS DURING COVID-19
por: HOCHBERG, CHAD, et al.
Publicado: (2021)

PERINATAL ECLS IN COVID-19
por: CARLISLE, G., et al.
Publicado: (2022)

PNEUMOTHORAX, PNEUMOMEDIASTINUM, AND SUBCUTANEOUS EMPHYSEMA IN COVID-19 ARDS: OUR EXPERIENCE
por: FALSINI, L., et al.
Publicado: (2022)

RECURRENT ISCHEMIC STROKES IN A PATIENT WITH SEVERE COVID-19 INFECTION AND PHOSPHATIDYLSERINE ANTIBODIES
por: Iguina, Michele, et al.
Publicado: (2020)

COMPARISON OF HIGHER VERSUS LOWER DOSE STEROID ADMINISTRATION IN PATIENTS WITH COVID-19 AND ACUTE HYPOXEMIC RESPIRATORY FAILURE ON INHALED EPOPROSTENOL
por: RIEGO, MARIA ATHENA, et al.
Publicado: (2022)

CLINICAL OUTCOMES OF USING PROPOFOL IN PATIENTS WITH COVID-19 ON MECHANICAL VENTILATION
por: SAHA, PRATIK, et al.
Publicado: (2022)

Effectiveness of Mechanical Chest Compression Devices over Manual Cardiopulmonary Resuscitation: A Systematic Review with Meta-analysis and Trial Sequential Analysis
por: Sheraton, Mack, et al.
Publicado: (2021)

ASSESSMENT OF A CELLULAR HOST RESPONSE TEST AS A SEPSIS DIAGNOSTIC FOR PATIENTS PRESENTING TO THE ED SUSPECTED OF COVID-19 OR OTHER RESPIRATORY INFECTIONS
por: ONEAL, HOLLIS, et al.
Publicado: (2021)

COVID-19-RELATED COAGULOPATHY IN CRITICALLY ILL PATIENTS: EXPERIENCE FROM AN ACADEMIC MEDICAL CENTER
por: THAYYIL JAYAKRISHNAN, THEJUS, et al.
Publicado: (2021)

SYSTEMIC STEROIDS IN COVID-19 PNEUMONIA: A RETROSPECTIVE ANALYSIS
por: GREWAL, S., et al.
Publicado: (2022)

LIVER ABSCESS DEVELOPMENT IN THE POSTACUTE COVID-19 PHASE
por: DUCHNOWSKA, ANNA, et al.
Publicado: (2022)

PRONE POSITIONING IN COVID-19 VS NON-COVID-19 ARDS IN THE EARLY COVID-19 PANDEMIC
por: LIEBERMAN, ALLYSON E, et al.
Publicado: (2022)

COVID-19 LEARNINGS IN 22 INTENSIVE CARE UNITS IN LATIN AMERICA DURING THE FIRST WAVE: COLLABORATIVE MULTICENTER STUDY
por: ARENAS VILLAMIZAR, A.R., et al.
Publicado: (2022)

THORACIC ULTRASOUND IN COVID-19: A PROSPECTIVE STUDY USING LUNG AND DIAPHRAGM ULTRASOUND IN EVALUATING DYSPNEA IN ICU SURVIVORS WITH COVID-19 IN A POST-ICU CLINIC
por: EMAN, G., et al.
Publicado: (2022)

COVID-19-ASSOCIATED THROMBOTIC THROMBOCYTOPENIA PURPURA (TTP)
por: JAIN, HANISH, et al.
Publicado: (2022)

COVID-19 AS A CONFOUNDER IN A CASE OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
por: MEMON, AREEKA, et al.
Publicado: (2022)

Association of body mass index with morbidity in patients hospitalised with COVID-19
por: Plataki, Maria, et al.
Publicado: (2021)

COVID-19 INFECTION AND PNEUMOMEDIASTINUM
por: KHAN, MOHAMMAD, et al.
Publicado: (2021)

ANCHORING IN THE TIME OF COVID-19
por: GIANNIOSIS, MARGARITA, et al.
Publicado: (2021)

CHARACTERISTICS OF SURVIVORS OF COVID-19 SEEN AT A POST-ACUTE COVID-19 SYNDROME CLINIC
por: GARNER, ORLANDO, et al.
Publicado: (2021)

Nutritional evaluation and management in patients with Covid-19 following hospitalization in intensive care units
por: Hoyois, A., et al.
Publicado: (2020)

DAPSONE-INDUCED METHEMOGLOBINEMIA IN COVID-19: A MIMIC OF "HAPPY HYPOXIA"
por: SHARMA, ALISHA, et al.
Publicado: (2022)

LUCINACTANT, A SYNTHETIC SURFACTANT FOR TREATMENT OF COVID-19-ASSOCIATED ARDS
por: GUARDIA, CARLOS G, et al.
Publicado: (2022)

AN UNUSUAL PRESENTATION OF LATERAL MEDULLARY STROKE IN THE SETTING OF COVID-19 INFECTION
por: BAHGAT, J., et al.
Publicado: (2022)

SILENT HYPOXIA IN COVID-19: IS IT MORE DANGEROUS? A RETROSPECTIVE COHORT STUDY
por: SIROHIYA, P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k4fdl2kglvqg92m5spd57k3k1e